-
2
-
-
0034913347
-
Elevated matrix metalloproteinase-2 and-9 in urine, but not in serum, are markers of type 1 diabetic nephropathy
-
Diamant M, Hanemaaijer R, Verheijen JH.et al. Elevated matrix metalloproteinase-2 and-9 in urine, but not in serum, are markers of type 1 diabetic nephropathy. Diabetes Med. 2001;18:423-424.
-
(2001)
Diabetes Med
, vol.18
, pp. 423-424
-
-
Diamant, M.1
Hanemaaijer, R.2
Verheijen, J.H.3
-
3
-
-
0035229441
-
Immunohistochemistry of MMPs and TIMPs
-
Okada Y. Immunohistochemistry of MMPs and TIMPs.Methods Mol Biol. 2001;151:359-65.
-
(2001)
Methods Mol Biol
, vol.151
, pp. 359-365
-
-
Okada, Y.1
-
4
-
-
0033780333
-
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension
-
Relationship to left ventricular mass and anti-hypertensive therapy
-
Li-Saw-Hee FL, Edmunds E, Blann A, Beevers DG, Lip GY. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol. 2000;75:43-47.
-
(2000)
Int J Cardiol
, vol.75
, pp. 43-47
-
-
Li-Saw-Hee, F.L.1
Edmunds, E.2
Blann, A.3
Beevers, D.G.4
Lip, G.Y.5
-
5
-
-
0037693895
-
Matrix metalloproteinases and tissueinhibitors of metalloproteinases: Structure, function, andbiochemistry
-
Visse R and Nagase H. Matrix metalloproteinases and tissueinhibitors of metalloproteinases: structure, function, andbiochemistry. Circ Res. 2003;92:827-839.
-
(2003)
Circ Res
, vol.92
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
6
-
-
0032769379
-
Cellular mechanisms of diabetic vascular hypertrophy
-
Vranes D, Cooper ME, Dilley RJ. Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res. 1999;57(1):8-18.
-
(1999)
Microvasc Res
, vol.57
, Issue.1
, pp. 8-18
-
-
Vranes, D.1
Cooper, M.E.2
Dilley, R.J.3
-
7
-
-
0037407721
-
Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy
-
Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2003;44(5):2163-70.
-
(2003)
Invest Ophthalmol Vis Sci
, vol.44
, Issue.5
, pp. 2163-2170
-
-
Noda, K.1
Ishida, S.2
Inoue, M.3
Obata, K.4
Oguchi, Y.5
Okada, Y.6
Ikeda, E.7
-
8
-
-
0034786386
-
Peripheral blood level alterations of 1TIMP-1 MMP-2 and MMP- 9 in patients with type 1 diabetes
-
Maxwell PR, Timmes PM, Chandran S, Gordon D. Peripheral blood level alterations of 1TIMP-1 MMP-2 and MMP- 9 in patients with type 1 diabetes. Diabetes Med. 2001;18: 777-780.
-
(2001)
Diabetes Med
, vol.18
, pp. 777-780
-
-
Maxwell, P.R.1
Timmes, P.M.2
Chandran, S.3
Gordon, D.4
-
9
-
-
0037324289
-
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease
-
Marx N, Froehlich J, Siam L, et al. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2003;23:283-288.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 283-288
-
-
Marx, N.1
Froehlich, J.2
Siam, L.3
-
10
-
-
0032849144
-
Competitive RT-PCR for measuring metalloproteinase gene expression in human mesangial cells exposed to a hyperglycemic environment
-
Death AK, Yue DK, Turtle JR. Competitive RT-PCR for measuring metalloproteinase gene expression in human mesangial cells exposed to a hyperglycemic environment. Biotechniques. 1999;27:512-518.
-
(1999)
Biotechniques
, vol.27
, pp. 512-518
-
-
Death, A.K.1
Yue, D.K.2
Turtle, J.R.3
-
11
-
-
79953116450
-
-
Cairo University, In collaboration with Wright State University. School of Medicine, Department of Community Health Lifespan. Health Research Center. From a Total Sample Size of 33189 Girls and Boys Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center
-
Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center. Cairo University, In collaboration with Wright State University. School of Medicine. Department of Community Health lifespan. Health Research Center. From a total sample size of 33189 girls and boys. Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center, 2003.
-
(2003)
Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center
-
-
-
12
-
-
75149130955
-
Diagnosis and Classification of Diabetes Mellitus
-
American Diabetes Association (ADA)
-
American Diabetes Association (ADA). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010; 33(1):562-569.
-
(2010)
Diabetes Care
, vol.33
, Issue.1
, pp. 562-569
-
-
-
13
-
-
11844291920
-
Diabetic nehpropathy: Diagnosis,prevention and treatment
-
Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML. Diabetic nehpropathy: diagnosis,prevention and treatment. Diabetes Care. 2005;28:164-176.
-
(2005)
Diabetes Care
, vol.28
, pp. 164-176
-
-
Gross, J.L.1
de Azevedo, M.J.2
Silveiro, S.P.3
Canani, L.H.4
Caramori, M.L.5
-
14
-
-
0027534228
-
A new international reference preparation for proteins in human serum
-
Johnson AM. A new international reference preparation for proteins in human serum. Arch Pathol Med. 1993;117:19-31.
-
(1993)
Arch Pathol Med
, vol.117
, pp. 19-31
-
-
Johnson, A.M.1
-
15
-
-
0036240803
-
Screening for vascular complications in children and adolescents with type 1 diabetes mellitus
-
Chiarelli F, Mohn A, Tumini S, Trotta D, Verrotti A. Screening for vascular complications in children and adolescents with type 1 diabetes mellitus. Horm Res. 2002;57(Suppl 1):113-6.
-
(2002)
Horm Res
, vol.57
, Issue.SUPPL. 1
, pp. 113-116
-
-
Chiarelli, F.1
Mohn, A.2
Tumini, S.3
Trotta, D.4
Verrotti, A.5
-
16
-
-
33846000986
-
Increased circulatory MMP- 2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus
-
Shiau MY, Tsai ST, Tsai KJ et al. Increased circulatory MMP- 2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med. 2006; 73(7):1024-8.
-
(2006)
Mt Sinai J Med
, vol.73
, Issue.7
, pp. 1024-1028
-
-
Shiau, M.Y.1
Tsai, S.T.2
Tsai, K.J.3
-
17
-
-
34548435665
-
Matrix metalloproteinase-2 dysregulation in type 1 diabetes
-
Thrailkill KM, Bunn RC, Moreau CS et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care. 2007;30(9):2321-6.
-
(2007)
Diabetes Care
, vol.30
, Issue.9
, pp. 2321-2326
-
-
Thrailkill, K.M.1
Bunn, R.C.2
Moreau, C.S.3
-
18
-
-
1042291851
-
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes
-
Derosa G, Avanzini MA, Geroldi D et al. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes. Diabetes Care. 2005;27(1):273-274.
-
(2005)
Diabetes Care
, vol.27
, Issue.1
, pp. 273-274
-
-
Derosa, G.1
Avanzini, M.A.2
Geroldi, D.3
-
19
-
-
70349811339
-
Matrix metalloproteinases in subjects with type 1 diabetes
-
Gharagozlian S, Svennevig K, Bangstad HJ, Winberg JO, Kolset SO. Matrix metalloproteinases in subjects with type 1 diabetes. BMC Clin Pathol. 2009;9:7.
-
(2009)
BMC Clin Pathol
, vol.9
, pp. 7
-
-
Gharagozlian, S.1
Svennevig, K.2
Bangstad, H.J.3
Winberg, J.O.4
Kolset, S.O.5
-
20
-
-
33747611521
-
Reduced expression of vascular endothelial growth factor paralleled with theincreased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and-9 in human type 2 diabetic arterial vasculature
-
Chung AW, Hsiang YN, Matzke LA et al. Reduced expression of vascular endothelial growth factor paralleled with theincreased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and-9 in human type 2 diabetic arterial vasculature. Circ Res. 2006; 99:140-148.
-
(2006)
Circ Res
, vol.99
, pp. 140-148
-
-
Chung, A.W.1
Hsiang, Y.N.2
Matzke, L.A.3
-
21
-
-
0038173265
-
High glucose alters matrix metalloproteinase expression in two key vascular cells: Potential impact on atherosclerosis in diabetes
-
Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis. 2003;168:263-269.
-
(2003)
Atherosclerosis
, vol.168
, pp. 263-269
-
-
Death, A.K.1
Fisher, E.J.2
McGrath, K.C.3
Yue, D.K.4
-
22
-
-
0038170437
-
High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells
-
Hao F, Yu JD. High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells. Acta PharmacoSin. 2003;24:534-538.
-
(2003)
Acta PharmacoSin
, vol.24
, pp. 534-538
-
-
Hao, F.1
Yu, J.D.2
-
23
-
-
79953105793
-
-
September 5-9, 2004 Munich, Germany. Poster 1064
-
Lewandowska AB, Randeva HS, Komorowski KC, et al. Selective elevation of matrix metalloproteinase-2 in aqueous humour in subjects with proliferative diabetic retinopathy.Program and abstracts of the 40 th AnnualMeeting of the European Association for the Study of Diabetes. September 5-9, 2004, Munich, Germany. Poster 1064.
-
Selective Elevation of Matrix Metalloproteinase-2 In Aqueous Humour In Subjects With Proliferative Diabetic Retinopathy.Program and Abstracts of the 40 Th AnnualMeeting of the European Association For the Study of Diabetes
-
-
Lewandowska, A.B.1
Randeva, H.S.2
Komorowski, K.C.3
-
24
-
-
0036190236
-
Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
-
Bangstad HJ, Osterby R, Rudberg S. et al. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia. 2002;45(2):253-261.
-
(2002)
Diabetologia
, vol.45
, Issue.2
, pp. 253-261
-
-
Bangstad, H.J.1
Osterby, R.2
Rudberg, S.3
-
25
-
-
0035988186
-
Structural changes in renal arterioles in Type 1diabetic patients
-
Osterby R, Hartmann A, Bangstad HJ. Structural changes in renal arterioles in Type 1diabetic patients. Diabetologia. 2002;45(4):542-549.
-
(2002)
Diabetologia
, vol.45
, Issue.4
, pp. 542-549
-
-
Osterby, R.1
Hartmann, A.2
Bangstad, H.J.3
-
26
-
-
33645456579
-
Therapeutic potential of angiostatin in diabetic nephropathy
-
Zhang SX, Wang JJ, Lu K et al. Therapeutic potential of angiostatin in diabetic nephropathy. J Am Soc Nephrol. 2006;17:475-486.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 475-486
-
-
Zhang, S.X.1
Wang, J.J.2
Lu, K.3
-
27
-
-
33744474294
-
Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats
-
Sun SZ, Wang Y, Li Q. et al. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Chin Med J (Engl). 2006;119:814-821.
-
(2006)
Chin Med J (Engl)
, vol.119
, pp. 814-821
-
-
Sun, S.Z.1
Wang, Y.2
Li, Q.3
-
28
-
-
25144442812
-
Establishment of a diabetic mouse model with progressive diabetic nephropathy
-
Inada A, Nagai K, Arai H et al. Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am JPathol. 2005;167:327-336.
-
(2005)
Am JPathol
, vol.167
, pp. 327-336
-
-
Inada, A.1
Nagai, K.2
Arai, H.3
-
29
-
-
0034943382
-
High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1
-
Singh R, Song RH, Alavi N et al. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol. 2001;9:249-257.
-
(2001)
Exp Nephrol
, vol.9
, pp. 249-257
-
-
Singh, R.1
Song, R.H.2
Alavi, N.3
-
30
-
-
0034880505
-
Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients
-
Romanic AM, Burns-Kurtis CL, Ao Z, Arleth AJ, Ohlstein EH. Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients. Am J Physio. 2001;281:F309-F317.
-
(2001)
Am J Physio
, vol.281
-
-
Romanic, A.M.1
Burns-Kurtis, C.L.2
Ao, Z.3
Arleth, A.J.4
Ohlstein, E.H.5
-
31
-
-
79953108737
-
New Developments in Retinopathy
-
Posted: 12/16/2004; Updated: 12/21/2004
-
Hammes, HP. New Developments in Retinopathy. Medscape Diabetes & Endocrinology, 2004. Posted: 12/16/2004; Updated: 12/21/2004.
-
(2004)
Medscape Diabetes & Endocrinology
-
-
Hammes, H.P.1
-
32
-
-
18744362465
-
Matrix metalloproteinases in early diabetic retinopathy and their rolein alteration of the blood-retinal barrier
-
Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their rolein alteration of the blood-retinal barrier. Lab Invest. 2005;85: 597-607.
-
(2005)
Lab Invest
, vol.85
, pp. 597-607
-
-
Giebel, S.J.1
Menicucci, G.2
McGuire, P.G.3
Das, A.4
-
33
-
-
0033810812
-
Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy
-
Salzmann Jm, Limb GA, Khaw PT et al. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol. 2000;84:1091-1096.
-
(2000)
Br J Ophthalmol
, vol.84
, pp. 1091-1096
-
-
Salzmann, J.M.1
Limb, G.A.2
Khaw, P.T.3
|